Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
from Latest Science News -- ScienceDaily https://ift.tt/2Wucku2
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment